Business
Why the CSL (ASX:CSL) share price has rebounded 13% since March
The CSL Limited (ASX: CSL) share price has been rebounding lately after hitting a 52-week low of $242.00 on 9 March. Since then, the company has gained 12.95%, with CSL shares currently trading at $273.35.
The global biotech has been busy producing the AstraZeneca COVID-19 vaccine while attempting to combat plasma collection concerns. Could this be the catalyst for its recent share price rise?
What’s driving the CSL share price higher?
Investors appear upbeat about the company’s progress to address its current issues as well as its attempts to open up new opportunities.
As announced on 14 April, CSL has been focused on increasing its plasma-protein production through its launch of a global challenge. The company is inviting…
-
Noosa News15 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
Noosa News18 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General14 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
General16 hours agoCanberra man named as doctor accused of rape after suppression order lifted